Every GLP-1 price on the internet is quoted at a dose, and almost none of them says which. That matters more than the number does, because a titration schedule moves nearly everyone off their starting dose inside about four months — and the published figure was written for the dose they are leaving.
The census
Of 456 sellers on this desk publishing a figure this site will rank, 278 — 61% — publish nothing whatever about dose behavior. Not a ladder, not a statement that the rate holds, not a note that it rises — a silence counted alongside the others in what a headline leaves out. 143 state their rate is flat at every dose. 35 state that it scales.
Why it dominates the arithmetic
Take the median published figure for compounded semaglutide by injection, which on this corpus is $179 a month. Six months at that rate is $1,074 — but only for a buyer whose dose does not move. A seller whose price re-sets at each titration step can easily exceed that total before month six, while the difference between the twenty-fifth and seventy-fifth percentile of the whole market is $81 a month. The dose question is worth more than the shopping-around question, which the full price distribution puts in perspective.
What to ask, and where to look
The question is one sentence: does this figure change as my dose goes up, and if so, what does it become? A seller that answers it in writing has told you something material. A seller that cannot has told you something too. Flat or rising groups every priced seller by what it states, and the six-month totals show what each figure implies if it holds.
Counts are computed from this site’s own price records at build time, most recently read September 2026.